天士力制药2005年半年度报告（节录）_医药资讯

财务资料1、主要会计数据及财务指标单位:元 币种:人民币主要会计数据本报告期末上年度期末本报告期末比上年度期末增减（％）流动资产1,252,481,836.201,097,236,200.9414.15流动负债884,133,162.93801,269,540.3410.34总资产2,434,348,924.492,201,021,206.1310.60股东权益（不含少数股东权益）1,184,372,746.391,200,259,469.73-1.32每股净资产4.164.21-1.32调整后的每股净资产4.094.17-1.92报告期（1－6月）上年同期本报告期比上年同期增减（％）净利润69,613,276.6660,233,506.6715.57扣除非经常性损益后的净利润70,189,755.2960,141,933.0516.71每股收益0.240.2115.57净资产收益率（%）5.885.530.35经营活动产生的现金流量净额50,083,352.8149,447,990.641.282、扣除非经常性损益项目和金额单位:元 币种:人民币非经常性损益项目金额委托投资损益-78,454.80扣除资产减值准备后的其他各项营业外收入、支出-422,795.54所得税影响数-75,178.51少数股东损益影响数-49.77合计-576,478.623、净资产收益率及每股收益单位:元 币种:人民币报告期利润净资产收益率（%）每股收益全面摊薄加权平均全面摊薄加权平均主营业务利润27.7826.951.151.15营业利润6.876.660.290.29净利润5.885.700.240.24扣除非经常性损益后的净利润5.935.750.250.254、利润及利润分配表单位:元 币种:人民币项 目合并母公司本期数上期数本期数上期数一、主营业务收入619,357,790.04532,751,857.09427,865,301.55390,622,134.95减：主营业务成本282,975,208.75198,515,438.04165,118,472.78104,980,536.38主营业务税金及附加7,314,071.246,863,655.805,813,339.335,627,881.28二、主营业务利润（亏损以“-”号填列）329,068,510.05327,372,763.25256,933,489.44280,013,717.29加：其他业务利润（亏损以“-”号填列）-701,078.25257,535.9813,480,356.61253,141.89减:营业费用142,456,213.61161,911,237.04133,487,449.91152,426,227.64管理费用85,570,726.3091,466,217.7470,543,329.0075,848,971.96财务费用18,986,839.335,822,636.7817,955,240.894,141,045.16三、营业利润（亏损以“-”号填列）81,353,652.5768,430,207.6748,427,826.2547,850,614.42加：投资收益（损失以“-”号填列）-742,966.92-85,382.027,888,053.534,320,748.38补贴收入50,000.00营业外收入5,982.2326,486.383,700.0023,148.18减：营业外支出428,777.771,098,254.07428,777.77794,507.23四、利润总额（亏损总额以“-”号填列）80,187,890.1167,323,057.9655,890,802.0151,400,003.75减：所得税8,683,080.575,495,429.437,200,412.272,602,858.51减：少数股东损益1,891,532.881,594,121.86加：未确认投资损失(合并报表填列)五、净利润（亏损以“-”号填列）69,613,276.6660,233,506.6748,690,389.7448,797,145.24加：年初未分配利润259,597,325.19198,409,855.44258,984,407.17205,133,921.50其他转入六、可供分配的利润329,210,601.85258,643,362.11307,674,796.91253,931,066.74减：提取法定盈余公积提取法定公益金提取职工奖励及福利基金(合并报表填列)提取储备基金提取企业发展基金利润归还投资七、可供股东分配的利润329,210,601.85258,643,362.11307,674,796.91253,931,066.74减：应付优先股股利提取任意盈余公积应付普通股股利85,500,000.0085,500,000.0085,500,000.0085,500,000.00转作股本的普通股股利八、未分配利润(未弥补亏损以“-”号填列)243,710,601.85173,143,362.11222,174,796.91168,431,066.74补充资料：1.出售、处置部门或被投资单位所得收益2.自然灾害发生的损失3.会计政策变更增加(或减少)利润总额4.会计估计变更增加(或减少)利润总额5.债务重组损失6.其他 详见《天津天士力制药股份有限公司2005年半年度报告》（据“上海证券交易所”；医药网整理，严禁转载）

本文来源于网络，版权归作者所有，如有侵权请联系网站客服。